Company performance
Current Price
as of Jan 23, 2025$19.13
P/E Ratio
14.25
Market Cap
$1.11B
Description
Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.
Metrics
Overview
- HQParsippany, NJ
- SectorHealth Technology
- IndustryMedical Specialties
- TickerEMBC
- Price$19.13+2.08%
Trading Information
- Market cap$1.11B
- Float92.61%
- Average Daily Volume (1m)405,123
- Average Daily Volume (3m)413,694
- EPS$1.36
Company
- Revenue$1.12B
- Rev growth (1yr)0.21%
- Net income$78.30M
- Gross margin64.90%
- EBITDA margin29.16%
- EBITDA$327.50M
- EV$2.17B
- EV/Revenue1.94
- P/E14.25
- P/S0.99
- P/BN/A
Documents
SEC Filings
Earnings Calls
Factset Street Account